Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Spencer

Showing results (1-10 of 311) with videos related to

Pageof 32
Sort By:
Blood|July 30, 2025
New prognostic systems for multiple myeloma in the context of contemporary therapiesAndrew Spencer
Clinical Medicine (London, England)|March 1, 2012
The white papers, quality indicators and clinical responsibilityAndrew Spencer
Blood|November 13, 2010
No longer the poor relationsAndrew Spencer
BMJ (Clinical Research Ed.)|May 28, 2016
Future of clinical codingStephen Andrew Spencer
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 5, 2012
National neonatal data to support specialist care and improve infant outcomesAndrew Spencer, Neena Modi
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2018
Analysis of Circulating Tumor DNASridurga Mithraprabhu, Andrew Spencer
Molecular Cancer Therapeutics|August 24, 2011
Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myelomaTiffany Khong, Andrew Spencer
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The role of cell free DNA and liquid biopsies in haematological conditionsNicholas Bingham, Andrew Spencer
Oncotarget|December 7, 2017
Circulating tumour DNA analysis in multiple myelomaSridurga Mithraprabhu, Andrew Spencer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Successful use of haploidentical stem-cell transplantation with KIR mismatch as initial therapy for poor-risk myelodysplastic syndromeMark A Dawson, Andrew Spencer
Pageof 32

Showing results (1-10 of 311) with videos related to

Sort By:
Pageof 32
Blood|July 30, 2025
New prognostic systems for multiple myeloma in the context of contemporary therapiesAndrew Spencer
Clinical Medicine (London, England)|March 1, 2012
The white papers, quality indicators and clinical responsibilityAndrew Spencer
Blood|November 13, 2010
No longer the poor relationsAndrew Spencer
BMJ (Clinical Research Ed.)|May 28, 2016
Future of clinical codingStephen Andrew Spencer
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 5, 2012
National neonatal data to support specialist care and improve infant outcomesAndrew Spencer, Neena Modi
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2018
Analysis of Circulating Tumor DNASridurga Mithraprabhu, Andrew Spencer
Molecular Cancer Therapeutics|August 24, 2011
Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myelomaTiffany Khong, Andrew Spencer
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The role of cell free DNA and liquid biopsies in haematological conditionsNicholas Bingham, Andrew Spencer
Oncotarget|December 7, 2017
Circulating tumour DNA analysis in multiple myelomaSridurga Mithraprabhu, Andrew Spencer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Successful use of haploidentical stem-cell transplantation with KIR mismatch as initial therapy for poor-risk myelodysplastic syndromeMark A Dawson, Andrew Spencer
Pageof 32